Siqin Zhou

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Coronary Artery Bypass

Neoadjuvant Chemotherapy

Decision Making

Top Venues

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shi Hui Yang, Min Li Tey, Siqin Zhou, Phyu Nitar, Hanis Mariyah, Yirong R Sim, Grace Kusumawidjaja, Wen Yee Chay, Wong Fuh Yong, Ru Xin Wong
Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery. Journal of breast cancer 27 (2) (2024)
Shi Hui Yang, Min Li Tey, Siqin Zhou, Phyu Nitar, Hanis Mariyah, Yirong R Sim, Grace Kusumawidjaja, Wen Yee Chay, Wong Fuh Yong, Ru Xin Wong
Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery. Journal of breast cancer 27 (2) (2024)
Shi Hui Yang, Min Li Tey, Siqin Zhou, Phyu Nitar, Hanis Mariyah, Yirong R Sim, Grace Kusumawidjaja, Wen Yee Chay, Wong Fuh Yong, Ru Xin Wong
Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery. Journal of breast cancer 27 (2) (2024)
Shi Hui Yang, Min Li Tey, Siqin Zhou, Phyu Nitar, Hanis Mariyah, Yirong R Sim, Grace Kusumawidjaja, Wen Yee Chay, Wong Fuh Yong, Ru Xin Wong
Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery. Journal of breast cancer (2024)
Shi Hui Yang, Min Li Tey, Siqin Zhou, Phyu Nitar, Hanis Mariyah, Yirong R Sim, Grace Kusumawidjaja, Wen Yee Chay, Wong Fuh Yong, Ru Xin Wong
Correlation of Neutrophil-Lymphocyte and Albumin-Globulin Ratios With Outcomes in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy or Upfront Surgery. Journal of breast cancer 27 (2) (2024)